Entrada Therapeutics Inc

XNAS: TRDA

Value Stock, Under Radar

Download real time

7.94 -0.08 (-1.00%)

New 52W Low today

175.2K XNAS Volume

XNAS 04 Apr, 2025 5:30 PM (EDT)

298.5

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 6 analysts

Entrada Therapeutics Inc has a share price target of US$ 25, revenue growth forecast of -80.8%, and profit growth estimate of -321.1% for FY25, based on top 6 analyst calls.

Forecaster Screeners